Biosignalmessvorrichtung
Anmelder: OMRON Corporation, Omron Healthcare Co., Ltd. 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4732773
- Anmeldetag
- 6. August 2024
- Veröffentlichung
- 13. Februar 2025
- Rechtsraum
- EP
Abstract
To provide a biosignal measurement device that can achieve low power consumption while achieving highly accurate electrocardiographic measurement. The biosignal measurement device includes: a plurality of electrodes; a measurement unit including a detection circuit that detects a potential difference using the plurality of electrodes and configured to measure an electrocardiographic signal of a subject using the detection circuit; a battery configured to supply power to the detection circuit; and a selection unit configured to select a measurement electrode to be used for measurement of the electrocardiographic signal of the subject from the plurality of electrodes, based on the electrocardiographic signal of the subject, which is measured using at least some of the plurality of electrodes and the detection circuit. In addition, the measurement unit measures the electrocardiographic signal using the detection circuit and the measurement electrode.
Anmelder
- Firmen
- OMRON Corporation
Omron Healthcare Co., Ltd. - Land
- 🇯🇵 Japan
Japanisches Technologieunternehmen mit Sitz in Kyoto. Omron entwickelt Automatisierungstechnik, Steuerungen, Sensoren und Robotik für die Industrie sowie elektronische Bauteile und medizintechnische Geräte.
1.838 Patente in unserer Datenbank
Vertreten von
-
Isarpatent
Isarpatent · München